Cellular iron depletion weakens induction of heme oxygenase-1 by cadmium

Int J Biochem Cell Biol. 2011 Jan;43(1):88-97. doi: 10.1016/j.biocel.2010.09.025. Epub 2010 Oct 8.

Abstract

Heme oxygenase-1 is an inducible cytoprotective gene, although its induction by environmental factors is not completely understood. This study aimed to ascertain if specific nutritive factors or related compounds influence heme oxygenase-1 expression. In HCT-116 cells, cadmium increased heme oxygenase-1 enzymatic activity. This effect of cadmium was weaker in cells made iron-deficient with the iron chelator, desferrioxamine, which was associated with repression of heme oxygenase-1 protein and mRNA expression. The repression by desferrioxamine of cadmium-induced heme oxygenase-1 upregulation was reversed upon iron replenishment of the cells. Additionally, it was found that thiol antioxidants inhibited the heme oxygenase-1 upregulation caused by cadmium and also by ethacrynic acid, which each decreased intracellular glutathione as did buthionine sulfoxamine. Interestingly, cadmium and ethacrynic acid increased nuclear translocation of Nrf2 and subsequent heme oxygenase-1 expression, but buthionine sulfoxamine did not. Furthermore, NADPH oxidase inhibitors (diphenyleneiodonium and apocynin, and a superoxide scavenger (Tiron) inhibited cadmium-induced upregulation of heme oxygenase-1. Diphenyleneiodonium was the most potent and inhibited NADPH-cytochrome P450 reductase as well, whereas apocynin and Tiron did not. It is concluded that adequate amounts of iron, which at the atomic level can serve as the pivotal element of heme in NADPH oxidase, must be present in cells to permit what appears to be thiol redox-sensitive, NADPH oxidase-dependent upregulation of heme oxygenase-1. Thus, these findings are significant because they suggest that cells without adequate iron would be unable to fully express the stress gene, heme oxygenase-1, when confronted with the toxic metal, cadmium.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt / pharmacology
  • Antioxidants / pharmacology
  • Cadmium* / pharmacology
  • Deferoxamine / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Gene Expression / drug effects
  • HCT116 Cells
  • Heme Oxygenase-1* / antagonists & inhibitors
  • Heme Oxygenase-1* / biosynthesis
  • Heme Oxygenase-1* / genetics
  • Humans
  • Iron* / metabolism
  • NADPH Oxidases / genetics
  • NADPH Oxidases / metabolism*
  • NADPH-Ferrihemoprotein Reductase / genetics
  • NADPH-Ferrihemoprotein Reductase / metabolism*
  • NF-E2-Related Factor 2 / genetics
  • NF-E2-Related Factor 2 / metabolism*
  • Oxidation-Reduction
  • Up-Regulation / drug effects

Substances

  • Antioxidants
  • Enzyme Inhibitors
  • NF-E2-Related Factor 2
  • NFE2L2 protein, human
  • Cadmium
  • 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt
  • Iron
  • Heme Oxygenase-1
  • NADPH-Ferrihemoprotein Reductase
  • NADPH Oxidases
  • Deferoxamine